SPAC Presentation

Procaps' Transaction Process Transaction Summary / Process Overview ■ ■ PROCAPS Procaps is a leading pharmaceutical and healthcare company based in Latin America with global reach and well positioned to drive regional consolidation Union Acquisition Corp. II ("UAC II" - NASDAQ: LATN) is a US-listed-SPAC that brings deep experience in Consumer and Packaged Goods operating and investing throughout the Americas GROUP Procaps and UAC II have signed a definitive business combination agreement along with a fully-committed PIPE financing agreement The transaction values Procaps at US$1.1 bn on a post-merger basis, representing an attractive 10.75x multiple on expected 2021 EBITDA of US$105 mm Use of proceeds are three-fold: i) fund organic growth, ii) consummate accretive acquisitions, and iii) fund redemption of certain shares held by the IFC A group of leading investors has committed to participate in a common stock PIPE of US$100 mm at $10.00 per share that will close simultaneously with the business combination In a recently challenging SPAC PIPE market, we were able to complete this process one-week ahead of schedule and over-subscribed, which we believe validates Procaps Group's and its unique growth prospects Currently focused on raising additional institutional investor demand ..:: 4

View entire presentation